The role of environmental factors in rheumatic diseases

Bulletin on the Rheumatic Diseases

Volumn 51, Issue 10, 2002, Pages

  Wallace, Daniel J ^a   Weisman, Michael H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALIPHATIC HYDROCARBON; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CADMIUM; CAFFEINE; FISH OIL; GROUND WATER; HERBICIDE; MERCURY; ORGANIC SOLVENT; POLYVINYLCHLORIDE; RAPESEED OIL; SILICONE DERIVATIVE; THIAZIDE DIURETIC AGENT; TRYPTOPHAN;

ADJUVANT DISEASE; ALCOHOL CONSUMPTION; ALFALFA; AUTOIMMUNE DISEASE; BEHCET DISEASE; BROCCOLI; CLIMATE; COFFEE; COLD EXPOSURE; CONNECTIVE TISSUE DISEASE; CONTAMINATION; DISEASE TRANSMISSION; ENVIRONMENTAL FACTOR; EOSINOPHILIA MYALGIA SYNDROME; FIBROMYALGIA; GIANT CELL ARTERITIS; GLOMERULOPATHY; GOUT; HUMAN; IMMUNIZATION; INFLAMMATION; INJURY; LIFESTYLE; NONHUMAN; OCCUPATIONAL EXPOSURE; PREVALENCE; PSORIASIS; RAPESEED; RAYNAUD PHENOMENON; REVIEW; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RIGIDITY; SCLERODERMA; SELF REPORT; SEROLOGY; SMOKING; STRESS; SYSTEMIC LUPUS ERYTHEMATOSUS; TOBACCO; ULTRAVIOLET RADIATION; URANIUM MINE; VACCINATION;

EID: 30844460388     PISSN: 00075248     EISSN: 00075248     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Miller FW, Hess EV, Clauw DJ, Hertzman PA, Pincus T, Silver RM, et al: Approaches for identifying and defining environmentally associated rheumatic diseases. Arthritis Rheum 2000;43:243-9.
2. Yslava v Hughes Aircraft et al, 845 F Supp 705, 712 (D Ariz 1993), Dismissed by federal court in 1999 as junk science.
3. Rose NR: The silicone breast implant controversy. Arthritis Rheum 1996;39:1615-8.
4. Alonso-Ruiz A, Zea-Mendoza AC, Salazar-Vallinas JM, Raocamora-Ripoli A, Beltran-Guttierez J: Toxic oil syndrome: A syndrome with features overlapping with those of various forms of scleroderma. Semin Arthritis Rheum 1986;15:200-12.
5. Mayeno AN, Lin F, Foote CS, Loegering DA, Ames DA, Ames MM, et al: Characterization of Peak E, a novel amino acid associated with exposure to tryptophan from a single manufacturer. Science 1990;250:1707.
6. Hertzman PA, Falk H, Kilbourne EM, Page S, Shulman LE: The eosinophilia-myalgia syndrome: The Los Alamos Conference. J Rheumatol 1991;18:867-73.
7. Dodson VN, Dinman BD, Whitehouse WM, Nasr ANM, Magnuson HJ: Occupational acroosteolysis. Arch Environ Health 1971;22:83-91.
8. Wallace DJ, Wallace JB: Controversial syndromes and their relationship to fibromyalgia. In All About Fibromyalgia, Oxford, Oxford U Press, 2002, pp 94-100.
9. th ed, Philadelphia, Lippincott Williams & Wilkins, 2001, pp 33-64.
10. Rosenberg AM, Semchik KM, Mc Duffie HH, Ledingham DL, Cordeiro DM, Cessna AJ, et al: Prevalence of antinuclear antibodies in a rural population. J Toxicol Environ Health 1999;56:225-36, Part A.
11. Lahita RG: Special report: Adjusted lupus prevalence. Results of a marketing study by the Lupus Foundation of America. Lupus 1995;4:450-3.
12. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini DH, et al: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States, Arthritis Rheum 1998;41:778-89.
13. Hochberg MC, Perlmutter DL, Medsger TA, Steen V, Weisman MH, White B, et al: Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 1995;4:454-6.
14. Hennekens CH, Min-Lee I, Cook NR, Hebert PR, Karlson EW, LaMotte F, et al: Self-reported breast implants and connective-tissue diseases in female health professionals: A retrospective cohort study. JAMA 1996;275:616-21.
15. Arizona Department of Health Services: The Santa Cruz County Community Health Survey, Phoenix, 1994.
16. Walsh BT, Pope C, Reid M, Gall EP, Yocum DE, Clark LC: SLE in a United States-Mexico border community, J Clin Rheumatol 2001;7:3-9.
17. Albano SA, Santana-Sahagin E, Weisman MH: Cigarette smoking and rheumatoid arthritis. Sem Arthritis Rheum 2001;31:146-59.
18. Mayes MD: Scleroderma epidemiology. Rheum Dis Clin NA 1996;22:751-64.
19. Silman AJ, Hochberg MC: Occupational and environmental influences on scleroderma. Rheum Dis Clin NA 1996;22:737-49.
20. Kaufman LD, Varga J (eds): Rheumatic Diseases and the Environment, London, Arnold Publishers, 1999.
21. nd ed, 2001.
22. Nietert PJ, Sutherland SE, Silver RM, Pandey JP, Knapp RG, Hoel DG, Dosemeci M: Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 1998;41:1111-8.
23. Love LA: New environmental agents associated with lupus-like disorders. Lupus 1994;3:467-71.